2696
J. C. Barrow et al. / Bioorg. Med. Chem. Lett. 11 (2001) 2691–2696
H. C.; Addo, M. F.; Darrow, A. L.; Eckardt, A. J.; Hoekstra,
Acknowledgements
W. J.; McComsey, D. F.; Oksenberg, D.; Reynolds, E. E.;
Santulli, R. J.; Scarborough, R. M.; Smith, C. E.; White, K. B.
Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 12257. (c) McComsey,
D. F.; Hawkins, M. J.; Andrade-Gordon, P.; Addo, M. F.;
Oksenberg, D.; Maryanoff, B. E. Bioorg. Med. Chem. Lett.
1999, 9, 1423. (d) Nose, T.; Satoh, Y.; Fijita, T.; Ohno, M.;
Nakajima, M.; Inoue, Y.; Ogino, Y.; Costa, T.; Shimohigashi,
Y. Bull. Chem. Soc. Jpn. 1998, 71, 1661. (e) Bernatowicz, M. S.;
Klimas, C. E.; Hartl, K. S.; Peluso, M.; Allegretto, N. J.; Sei-
ler, S. M. J. Med. Chem. 1996, 39, 4879. (f) Zhang, H.-C.;
Derian, C. K.; Andrade-Gordon, P.; Hoekstra, W. J.;
McComsey, D. F.; White, K. B.; Poulter, B. L.; Addo, M. F.;
Cheung, W.-M.; Damiano, B. P.; Oksenberg, D.; Reynolds,
E. E.; Pandey, A.; Scarborough, R. M.; Maryanoff, B. E. J.
Med. Chem. 2001, 44, 1021.
The authors thank Mary Becker for help in the pre-
paration of this manuscript, N. N. Tsou and R. G. Ball
for X-ray crystallography analysis, and J. Murphy, S.
Pitzenberger, S. Varga, A. Coddington, C. Ross and H.
Ramjit for analytical support.
References and Notes
1. Golsack, N. R.; Chambers, R. C.; Dabbagh, K.; Laurent,
G. J. Int. J. Biochem. Cell Biol. 1998, 30, 641.
2. Vu, T. K.; Hung, D. T.; Wheaton, V. I.; Coughlin, S. R.
Cell 1991, 64, 1057.
3. (a) Coughlin, S. R. Proc. Natl. Acad. Sci. U.S.A. 1999, 96,
11023. (b) Dery, O.; Corvera, C. U.; Steinhoff, M.; Bunnett,
N. W. Am. J. Physiol. 1998, 274, C1429. (c) Hou, L.; Howells,
G. L.; Kapas, S.; Macey, M. G. Br. J. Haematol. 1998, 101, 1.
(d) Brass, L. F.; Molino, M. Thrombosis Haemostasis 1997, 78,
234. (e) Grand, R. J. A.; Turnell, A. S.; Grabham, P. W. Bio-
chem. J. 1996, 313, 353. (f) Hollenberg, M. D. TiPS 1996, 17,
3. (g) Coughlin, S. R. Nature 2000, 407, 258. (h) Macfarlane,
S. R.; Seatter, M. J.; Kanke, T.; Hunter, G. D.; Plevin, R.
Pharmacol. Rev. 2001, 53, 245. (i) O’Brien, P. J.; Molino, M.;
Kahn, M.; Brass, L. F. Oncogene 2001, 20, 1570.
4. Dery, O.; Bunnett, N. W. Biochem. Soc. Trans. 1999, 27 (2),
246.
5. (a) Ray, A.; Hedge, L. G.; Gupta, J. B. Thromb. Res. 1997,
87, 37. (b) Ogletree, M. L.; Natarajan, S.; Seiler, S. M. Per-
spect. Drug Discov. Des. 1993, 1, 527. (c) Pakala, R.; Liang,
C. T.; Benedict, C. R. Thromb. Res. 2000, 100, 89.
9. (a) Hutchins, S.; Chapman, K. Tetrahedron Lett. 1995, 36,
2583. (b) Hutchins, S.; Chapman, K. Tetrahedron Lett. 1994,
35, 4055. Screening was performed using the assay described in
ref 16.
10. Brown, H. C.; Ramachandran, P. V. Acc. Chem. Res. 1992,
25, 16. The stereochemical assignment of 4 was made by analogy.
11. Prepared as a 2 Msolution in dichloromethane from 4-
(methylamino-t-butylcarbonyl)-aniline and phosgene.
12. (a) Bentley, T. W.; Jones, R. V. H.; Larder, A. H.; Lock,
S. J. J. Chem. Soc., Chem. Commun. 1994, 2309. (b) Bentley,
T. W.; Jones, R. V. H.; Larder, A. H.; Lock, S. J. J. Chem.
Soc., Perkin Trans. 2 1998, 1407.
13. 9:1 for pipecolic acid, 10:1 for thioproline, 9:1 for cis 5-
methylproline and cis 5-ethylproline, and 1:1 for trans 5-
methyl proline.
14. Li, H.; Sakamoto, T.; Kikugawa, Y. Tetrahedron Lett.
1997, 38, 6677.
6. Hammes, S. R.; Coughlin, S. R. Biochemistry 1999, 38,
2486.
15. (a) Houssin, R.; Vaccher, M. P.; Henichard, J. P.; Lesieur,
D. Heterocycles 1992, 34, 1343. (b) Perrone, R.; Berardi, F.;
Leopoldo, M.; Tortorella, V.; Lograno, M.; Daniele, E.;
Govoni, S. J. Med. Chem. 1992, 35, 3045.
16. Cook, J. J.; Sitko, G. R.; Bednar, B.; Condra, C.; Mellott,
M. J.; Feng, D. M.; Nutt, R. F.; Shafer, J. A.; Gould, R. J.;
Connolly, T. M. Circulation 1995, 91, 2961.
7. (a) Ahn, H. S. A.; Arik, L.; Boykow, G.; Burnett, D. A.;
Caplen, M. A.; Czarniecki, M.; Domalski, M. S.; Foster, C.;
Manna, M.; Stamford, A. W.; Wu, Y. Bioorg. Med. Chem.
Lett. 1999, 9, 2073. (b) Alexopoulos, K. A.; Matsoukas, J.;
Tselios, T.; Roumelioti, P.; Mavromoustakos, T.; Holada, K.
Amino Acids 1998, 15, 211. (d) Kato, Y.; Kita, Y.; Nishio, M.;
Hirasawa, Y.; Ito, K.; Yamanaka, T.; Motoyama, Y.; Seki, H.
Eur. J. Pharmacol. 1999, 384, 197.
17. X-ray crystallographic analysis on compound 11k
ꢀ
˚
revealed an N–O distance of 2.83 A with an angle of 144
which would be appropriate for an intramolecular H-bond.
8. (a) Feng, D. M.; Veber, D. F.; Connolly, T. M.; Condra,
C.; Tang, M. J.; Nutt, R. F. J. Med. Chem. 1995, 38, 4125. (b)
Andrade-Gordon, P.; Maryanoff, B. E.; Derian, C. K.; Zhang,
18. It is possible, however, to achieve greater inhibition of
thrombin-stimulated secretion by using lower concentrations
of thrombin agonist.